Rule · CVM · 17 Dec 2008

CVM Instruction No. 475 of December 17, 2008

Publicly held companies must disclose qualitative and quantitative information on all financial instruments in specific explanatory notes that are true, complete, consistent, and written in clear, objective, and concise language. Quantitative data must appear in table form segregating speculative derivatives from hedges, alongside a sensitivity analysis table identifying material risks, methods, assumptions, and three scenarios: likely, -25%, and -50% deterioration. For hedged derivatives, companies must disclose the protected element and instrument separately to show net exposure across these scenarios. This Instruction enters into force upon publication and revokes CVM Instruction No. 235 of March 23, 1995.

BrazilComissão de Valores Mobiliários
Annotations and obligations
20 obligations · 35 definitions · 50 reporting items
  • Obligation 20
  • Definition / condition 35
  • Reporting template 50
  • background, boilerplate

Lineage: In force

amendssupersedesissued underrefers toproposed or not in RegAlertarrows run from the older text to the one that changes it

Timeline

This document supersedes: CVM Instruction No. 235 of March 23, 1995

What changed in the obligations

Against CVM Instruction No. 235 of March 23, 1995 (1995-03-23)

16 new obligations · 1 changed obligation · 3 not carried over

1 obligation is the same in both texts.

Changed (1)
  • What must be done
    Before
    Art. 1. Publicly-held companies that possess financial instruments, recognized or not as an asset or liability in their balance sheet, must disclose, in an explanatory note annexed to their financial statements and to the quarterly information - ITR, the market value of these financial instruments, in accordance with article 3 of this Instruction. in the old text
    Now
    Art. 1 Publicly held companies must disclose, in a specific explanatory note, qualitative and quantitative information on all their financial instruments, recognized or not as an asset or liability in their balance sheet. in this text
New in this text (16)
  • § 1 The explanatory notes referred to in the caput must be true, complete, and consistent. in this text
  • § 2 The explanatory notes referred to in the caput must be written in clear, objective, and concise language. in this text
  • § 4 The quantitative information of the explanatory note referred to in the caput must be presented in table form, observing, where applicable, the example contained in Annex I. in this text
  • § 5 The table for presenting the quantitative information referred to in § 4 must segregate speculative derivative financial instruments from those intended to protect exposure to risks (hedge). in this text
  • § 6 Any other data necessary for users of the financial statements to be able to evaluate the quantitative information must be disclosed. in this text
  • Art. 3 Publicly held companies, in addition to the provisions of item 59 of CPC 14 – Financial Instruments: Recognition, Measurement, and Disclosure, must disclose a sensitivity analysis demonstration table, for each type of market risk considered relevant by management, arising from financial instruments, to which the entity is exposed at the end of each period, including all operations with d… in this text
  • § 1 The sensitivity analysis demonstration table referred to in the caput must be disclosed and prepared as follows: I - identify the types of risk that can generate material losses for the company, including operations with derivative financial instruments originating these risks; in this text
  • II – discriminate the methods and assumptions used in preparing the sensitivity analysis; in this text
  • III - define the most likely scenario, in management's assessment, plus 2 (two) scenarios that, if they occur, may generate adverse results for the company; in this text
  • IV - estimate the impact of the defined scenarios on the fair value of the financial instruments operated by the company; and in this text
  • V - prepare the sensitivity analysis demonstration in table form, considering the relevant financial instruments, including derivatives, and the selected risks, in rows, and the defined scenarios, in columns. in this text
  • § 2 In the definition of the scenarios referred to in item III of § 1, the following must necessarily be used: I - a situation considered likely by management and referenced by an independent external source (e.g.: prices of futures contracts traded on stock and commodity exchanges and futures); in this text
  • § 2 In the definition of the scenarios referred to in item III of § 1, the following must necessarily be used: II - a situation, with a deterioration of at least 25% (twenty-five percent) in the considered risk variable; and in this text
  • § 2 In the definition of the scenarios referred to in item III of § 1, the following must necessarily be used: III - a situation, with a deterioration of at least 50% in the considered risk variable. in this text
  • Art. 4 For operations with derivative financial instruments carried out for the purpose of hedge, the company must disclose the object (the element being protected) and the derivative financial instrument of protection in separate lines of the sensitivity analysis demonstration table, in order to inform about the company's net exposure, in each of the three scenarios mentioned in art. 3, § 2. in this text
  • The company must indicate how it proceeded with the accounting of derivatives designated for the purpose of hedge, in accordance with the provisions of Pronouncement CPC 14 – Financial Instruments: Recognition, Measurement, and Disclosure. in this text
Not carried over (3)
  • Art. 5. In the negotiation of financial instruments made at a value above the market value and combined with a credit operation, the following must be observed: I - in publicly-held companies selling the securities and financing the credit operation, the gain resulting from the difference between the sale value and the market value of the security must be recorded as a reduction of the asset repr… in the old text
  • Art. 5. In the negotiation of financial instruments made at a value above the market value and combined with a credit operation, the following must be observed: II - in publicly-held companies purchasing the securities, the difference between the acquisition value and the market value of the security must be recorded in a contra-asset and contra-liability account, and this contra-liability accoun… in the old text
  • Art. 6. The gain on the acquisition of a financial instrument whose market value is lower than its face value, even in cases where it can be used to settle debts, will only be recognized as it is effectively realized. in the old text

“Not carried over” means the sentence has no counterpart in this text; the rule can still be in force in another text.

Similar documents from other regulators

More like this from CVM

CVM published 2 documents in the last 30 days. We email you each new one the day it's published.

Source: Comissão de Valores Mobiliários — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated